{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:31:42Z","timestamp":1779309102894,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10157-026-02821-0","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:38:50Z","timestamp":1769848730000},"page":"706-717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nationwide questionnaire analysis on awareness of general practitioners for the management of chronic kidney disease in Japan"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1284-9728","authenticated-orcid":false,"given":"Kazuo","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Tatematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuguru","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Isozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Imura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munehiro","family":"Kitada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"2821_CR1","unstructured":"Japanese Society of Nephrology, Evidence-based Clinical practice Guideline for CKD 2023. Tokyo: Tokyo Igakusha; 2023. https:\/\/cdn.jsn.or.jp\/medic\/guideline\/pdf\/guide\/viewer.html?file=001-294.pdf. Accessed 30 Oct 2025."},{"issue":"1","key":"2821_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.kint.2016.09.015","volume":"91","author":"K Tanaka","year":"2017","unstructured":"Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, et al. Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int. 2017;91(1):227\u201334.","journal-title":"Kidney Int"},{"issue":"5","key":"2821_CR3","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.kint.2016.08.003","volume":"90","author":"K Matsushita","year":"2016","unstructured":"Matsushita K, Chen J, Sang Y, Ballew SH, Shimazaki R, Fukagawa M, et al. Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate. Kidney Int. 2016;90(5):1109\u201314.","journal-title":"Kidney Int"},{"key":"2821_CR4","unstructured":"Japanese Society of Nephrology, Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012. Tokyo: Tokyo Igakusha; 2012. https:\/\/jsn.or.jp\/guideline\/pdf\/CKDguide2012.pdf. Accessed 30 Oct 2025."},{"issue":"8","key":"2821_CR5","first-page":"1037","volume":"60","author":"Japanese Society of Nephrology","year":"2018","unstructured":"Japanese Society of Nephrology. Evidence-based Clinical practice Guideline for CKD 2018 edited by Japanese Society of Nephrology. Japanese J Nephrol. 2018;60(8):1037\u201393.","journal-title":"Japanese J Nephrol"},{"key":"2821_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11164779","author":"S Tatematsu","year":"2022","unstructured":"Tatematsu S, Kobayashi K, Utsunomiya Y, Hatta T, Isozaki T, Miyazaki M, et al. Comparison of the 2013 and 2019 nationwide surveys on the management of chronic kidney disease by general practitioners in Japan. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11164779.","journal-title":"J Clin Med"},{"key":"2821_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-021-02084-x","author":"S Tatematsu","year":"2021","unstructured":"Tatematsu S, Kobayashi K, Utsunomiya Y, Isozaki T, Hatta T, Kusumoto T, et al. Nationwide questionnaire survey on the management of chronic kidney disease for general practitioners in Japan. Clin Exp Nephrol. 2021. https:\/\/doi.org\/10.1007\/s10157-021-02084-x.","journal-title":"Clin Exp Nephrol"},{"key":"2821_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-022-01423-9","author":"T Hatta","year":"2022","unstructured":"Hatta T, Kobayashi K, Tatematsu S, Utsunomiya Y, Isozaki T, Miyazaki M, et al. The influence of Japanese general practitioners\u2019 familiarity with nephrologists on the management of chronic kidney disease. J Nephrol. 2022. https:\/\/doi.org\/10.1007\/s40620-022-01423-9.","journal-title":"J Nephrol"},{"issue":"10","key":"2821_CR9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10157-021-02084-x","volume":"25","author":"S Tatematsu","year":"2021","unstructured":"Tatematsu S, Kobayashi K, Utsunomiya Y, Isozaki T, Hatta T, Kusumoto T, et al. Nationwide questionnaire survey on the management of chronic kidney disease for general practitioners in Japan. Clin Exp Nephrol. 2021;25(10):1093\u2013102.","journal-title":"Clin Exp Nephrol"},{"key":"2821_CR10","unstructured":"Yamaguchi N IY. Survey and Research on the Current Status of Use of Clinical Practice Guidelines and Medical Quality Indicators in 2015; Comprehensive Research Report. Ministry of Health, Labour and Welfare Commissioned Project: EBM Promotion Project. 2016."},{"key":"2821_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55827-7","author":"T Tanaka","year":"2024","unstructured":"Tanaka T, Maruyama S, Chishima N, Akiyama H, Shimamoto K, Inokuchi S, et al. Population characteristics and diagnosis rate of chronic kidney disease by eGFR and proteinuria in Japanese clinical practice: an observational database study. Sci Rep. 2024. https:\/\/doi.org\/10.1038\/s41598-024-55827-7.","journal-title":"Sci Rep"},{"key":"2821_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-025-02695-8","author":"HA Uchida","year":"2025","unstructured":"Uchida HA, Wada J, Nagao Y, Ihara K. First-time diagnosis and referral practices for individuals with CKD by primary care physicians: a study of electronic medical records across multiple clinics in Japan. Clin Exp Nephrol. 2025. https:\/\/doi.org\/10.1007\/s10157-025-02695-8.","journal-title":"Clin Exp Nephrol"},{"key":"2821_CR13","doi-asserted-by":"publisher","first-page":"107750","DOI":"10.1016\/j.diabres.2019.05.029","volume":"155","author":"T Sugiyama","year":"2019","unstructured":"Sugiyama T, Imai K, Ihana-Sugiyama N, Tanaka H, Yanagisawa-Sugita A, Sasako T, et al. Variation in process quality measures of diabetes care by region and institution in Japan during 2015\u20132016: an observational study of nationwide claims data. Diabetes Res Clin Pract. 2019;155:107750.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"2821_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/00004872-199816070-00010","volume":"16","author":"T Ohkubo","year":"1998","unstructured":"Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16(7):971\u20135.","journal-title":"J Hypertens"},{"issue":"6","key":"2821_CR15","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/00004872-200406000-00009","volume":"22","author":"T Ohkubo","year":"2004","unstructured":"Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens. 2004;22(6):1099\u2013104.","journal-title":"J Hypertens"},{"issue":"4","key":"2821_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2014.20","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014;37(4):253\u2013390.","journal-title":"Hypertens Res"},{"issue":"9","key":"2821_CR17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42(9):1235\u2013481.","journal-title":"Hypertens Res"},{"key":"2821_CR18","unstructured":"Japanese Society of Nephrology. Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2024. Tokyo: Tokyo Igakusha; 2024. https:\/\/cdn.jsn.or.jp\/medic\/guideline\/pdf\/guide\/viewer.html?file=1-178_v3.pdf. Accessed 30 Oct 2025."},{"issue":"15","key":"2821_CR19","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou F-F, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436\u201346.","journal-title":"N Engl J Med"},{"key":"2821_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"The EMPA-KIDNEY Collaborative Group","year":"2023","unstructured":"The EMPA-KIDNEY Collaborative Group. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388:117\u201327.","journal-title":"N Engl J Med"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02821-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02821-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02821-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:09:36Z","timestamp":1776424176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02821-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2821"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02821-0","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kazuo Kobayashi has received lecture fees from Otsuka Pharmaceutical Co. LTD and Novartis pharma. Tsuguru Hatta has received lecture fees from Otsuka Pharmaceutical Co. LTD, Novartis pharma, Japan Eli Lilly and Company, Boehringer Ingelheim, Daiichi Sankyo Co., Ltd, and.Bayer Yakuhin LTd. Satoru Tatematsu, Taisuke Isozaki, Yosuke Nakayama, Junko Imura, Toshimasa Takahashi, Munehiro Kitada and Yasunori Utsunomiya declared no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The questionnaire was administered among members of the Japan Physicians Association. Explanations about the implementation of the questionnaire survey, the presentation of the results, and the writing of the manuscript were written on the questionnaire sheet. The responses to the questionnaire provided informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the ethical review board of the Japan Physicians Association 18 December 2023 (No 0.3\u20132312-01).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}